STOCK TITAN

Artisan Partners discloses 5.2% Ascendis Pharma (NASDAQ: ASND) stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Artisan Partners has disclosed a significant institutional stake in Ascendis Pharma A/S. Through several affiliated entities, it reports beneficial ownership of 3,225,885 American Depositary Shares, representing 5.2% of the class, based on 61,977,408 shares outstanding as of 12/30/2025.

Artisan Partners has shared voting power over 2,883,433 shares and shared dispositive power over 3,225,885 shares. The shares are held on behalf of discretionary clients of Artisan Partners Limited Partnership, which receive dividends and sale proceeds. The filing states the holdings are in the ordinary course of business and not for changing or influencing control of Ascendis Pharma.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (g) Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and the sole member of Artisan Investments GP LLC; Artisan Investments GP LLC is the general partner of Artisan Partners Limited Partnership; Artisan Partners Asset Management Inc. is the general partner of Artisan Partners Holdings LP.


SCHEDULE 13G




Comment for Type of Reporting Person: (g) Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and the sole member of Artisan Investments GP LLC; Artisan Investments GP LLC is the general partner of Artisan Partners Limited Partnership; Artisan Partners Asset Management Inc. is the general partner of Artisan Partners Holdings LP.


SCHEDULE 13G




Comment for Type of Reporting Person: (g) Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and the sole member of Artisan Investments GP LLC; Artisan Investments GP LLC is the general partner of Artisan Partners Limited Partnership; Artisan Partners Asset Management Inc. is the general partner of Artisan Partners Holdings LP.


SCHEDULE 13G




Comment for Type of Reporting Person: (e) Artisan Partners Limited Partnership is an investment adviser registered under section 203 of the Investment Advisers Act of 1940. (g) Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and the sole member of Artisan Investments GP LLC; Artisan Investments GP LLC is the general partner of Artisan Partners Limited Partnership; Artisan Partners Asset Management Inc. is the general partner of Artisan Partners Holdings LP.


SCHEDULE 13G



Artisan Partners Asset Management Inc.
Signature:/s/ Gregory K. Ramirez
Name/Title:Gregory K. Ramirez, Executive Vice President of Artisan Partners Asset Management Inc.
Date:02/03/2026
Artisan Partners Holdings LP
Signature:/s/ Gregory K. Ramirez
Name/Title:Gregory K. Ramirez, Executive Vice President of Artisan Partners Asset Management Inc., as the general partner of Artisan Partners Holdings LP
Date:02/03/2026
Artisan Investments GP LLC
Signature:/s/ Gregory K. Ramirez
Name/Title:Gregory K. Ramirez, Vice President of Artisan Investments GP LLC
Date:02/03/2026
Artisan Partners Limited Partnership
Signature:/s/ Gregory K. Ramirez
Name/Title:Gregory K. Ramirez, Vice President of Artisan Investments GP LLC, as the general partner of Artisan Partners Limited Partnership
Date:02/03/2026

Comments accompanying signature: Exhibit Index Exhibit 1 - Joint Filing Agreement dated 2/3/2026 by and among Artisan Partners Asset Management Inc., Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership.

FAQ

What stake does Artisan Partners report in Ascendis Pharma (ASND)?

Artisan Partners reports beneficial ownership of 3,225,885 Ascendis Pharma American Depositary Shares, or 5.2% of the class. This percentage is based on 61,977,408 shares outstanding as of December 30, 2025, as disclosed in the Schedule 13G/A amendment.

How much voting power does Artisan Partners have in Ascendis Pharma (ASND)?

Artisan Partners reports shared voting power over 2,883,433 Ascendis Pharma American Depositary Shares and no sole voting power. This means voting decisions for these shares are made jointly, consistent with its role managing assets for discretionary clients.

Who ultimately benefits from Artisan Partners’ Ascendis Pharma (ASND) holdings?

The Ascendis Pharma shares reported are held on behalf of discretionary clients of Artisan Partners Limited Partnership. Those clients, rather than Artisan Partners itself, are entitled to receive all dividends and proceeds from any sale of the reported shares, according to the filing.

Is Artisan Partners’ Ascendis Pharma (ASND) position intended to influence control?

The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ascendis Pharma. It also notes the holdings are not part of any transaction intended to affect issuer control.

Which Artisan entities are included in the Ascendis Pharma (ASND) Schedule 13G/A?

The Schedule 13G/A lists Artisan Partners Asset Management Inc., Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership. It also explains their control structure, with Artisan Partners Asset Management Inc. as general partner at the top of the ownership chain.

How is beneficial ownership of Ascendis Pharma (ASND) structured within Artisan Partners?

Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and sole member of Artisan Investments GP LLC. Artisan Investments GP LLC is general partner of Artisan Partners Limited Partnership, while Artisan Partners Asset Management Inc. is general partner of Artisan Partners Holdings LP, forming a control chain.
Ascendis Pharma

NASDAQ:ASND

ASND Rankings

ASND Latest News

ASND Latest SEC Filings

ASND Stock Data

13.81B
60.09M
0.78%
106.97%
4.43%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Denmark
ABINGDON, OXFORDSHIRE